IRIS UniCatt

Daniele, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.127
AS - Asia 5.901
EU - Europa 4.953
SA - Sud America 1.566
Continente sconosciuto - Info sul continente non disponibili 584
AF - Africa 265
OC - Oceania 20
Totale 20.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.840
SG - Singapore 2.509
IT - Italia 1.502
CN - Cina 1.301
BR - Brasile 1.242
DE - Germania 990
VN - Vietnam 701
SE - Svezia 646
FR - Francia 437
IE - Irlanda 282
GB - Regno Unito 222
ID - Indonesia 210
BD - Bangladesh 202
IN - India 188
JP - Giappone 184
UA - Ucraina 174
FI - Finlandia 169
AR - Argentina 150
RU - Federazione Russa 148
HK - Hong Kong 143
CA - Canada 125
CI - Costa d'Avorio 113
MX - Messico 90
TR - Turchia 78
PL - Polonia 77
IQ - Iraq 71
NL - Olanda 57
ES - Italia 51
KR - Corea 50
ZA - Sudafrica 48
AT - Austria 46
EC - Ecuador 41
PK - Pakistan 36
CO - Colombia 35
VE - Venezuela 34
BE - Belgio 31
SA - Arabia Saudita 26
UZ - Uzbekistan 21
AU - Australia 20
PE - Perù 20
TW - Taiwan 20
JO - Giordania 19
TN - Tunisia 18
MA - Marocco 15
MY - Malesia 15
NP - Nepal 15
CL - Cile 14
EG - Egitto 14
IR - Iran 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
JM - Giamaica 13
KE - Kenya 13
PH - Filippine 13
CZ - Repubblica Ceca 12
IL - Israele 12
PY - Paraguay 12
RO - Romania 12
RS - Serbia 12
AZ - Azerbaigian 11
CH - Svizzera 11
UY - Uruguay 11
DO - Repubblica Dominicana 10
DZ - Algeria 10
ET - Etiopia 9
LB - Libano 9
GR - Grecia 8
AL - Albania 7
CR - Costa Rica 7
LT - Lituania 7
SV - El Salvador 7
BO - Bolivia 6
NO - Norvegia 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
HN - Honduras 5
OM - Oman 5
PS - Palestinian Territory 5
BG - Bulgaria 4
HR - Croazia 4
KZ - Kazakistan 4
MD - Moldavia 4
PA - Panama 4
QA - Qatar 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
BZ - Belize 3
DK - Danimarca 3
LK - Sri Lanka 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
Totale 19.796
Salva come PNG Salva come JPEG
Città #
Singapore 1.221
San Jose 818
Ashburn 812
Chandler 623
Beijing 281
Dublin 258
Ho Chi Minh City 245
Rome 186
Hanoi 182
Los Angeles 182
Jakarta 173
Lauterbourg 172
Tokyo 168
Hefei 160
Milan 157
New York 136
Hong Kong 129
Wilmington 124
San Mateo 123
Jacksonville 116
Dallas 114
Abidjan 113
Nanjing 109
Boston 106
São Paulo 105
Dearborn 103
Cambridge 97
Princeton 94
Frankfurt am Main 92
Ann Arbor 90
St Louis 82
Helsinki 80
Moscow 78
Council Bluffs 75
Bar Harbor 71
Cattolica 66
Woodbridge 64
Redwood City 61
Warsaw 61
Fairfield 60
Chicago 56
The Dalles 56
Houston 52
Santa Clara 52
Seattle 51
Nürnberg 48
Naples 47
Kent 46
Tukwila 45
Boardman 44
Nuremberg 44
Seoul 42
Atlanta 41
Munich 41
Rio de Janeiro 41
Nanchang 39
Da Nang 38
Buffalo 37
Redmond 35
Chennai 34
London 34
Shanghai 34
Lawrence 33
Marseille 33
Paris 33
Brooklyn 32
Bari 31
Guangzhou 31
Shenyang 29
Curitiba 28
Montreal 28
Bremen 27
Izmir 27
Brasília 26
Norwalk 26
Orem 26
Phoenix 26
Toronto 26
Turku 26
Changsha 25
Baghdad 24
Belo Horizonte 24
Hangzhou 24
Amsterdam 23
Mountain View 23
Brussels 22
Denver 21
Mexico City 21
Vienna 21
Campinas 20
Kunming 20
Tianjin 20
Amman 19
Dhaka 19
Lappeenranta 19
Biên Hòa 18
Johannesburg 18
Haiphong 17
Hebei 17
Lancaster 17
Totale 9.864
Salva come PNG Salva come JPEG
Nome #
Neuropsichiatria dei disturbi dell’umore. In: Neuroscienze cliniche e del comportamento. Basi neurobiologiche e neuropsicologiche. Psicopatologia funzionale e neuropsichiatria A cura di C. Blundo 586
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 366
Basi neuro anatomiche delle funzioni cognitive e del comportamento 250
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 223
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 222
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 206
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 204
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 197
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 195
Sexual Behavior in Women with Bipolar Disorder 192
Spinal cord stimulation may improve gait and cognition in hereditary spastic paraplegia with mental retardation: a case report 181
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 177
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 175
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 172
Erratum: The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy (Neuroscience Letters (2001) 303 (87-90) PII: S0304394001016731) 170
New insights into the genetic etiology of Alzheimer's disease and related dementias 169
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 167
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 166
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 162
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 162
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 162
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 162
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging. 159
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 157
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides 155
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 154
Oral frailty and its determinants in older age: a systematic review 150
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 148
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 146
Analysis of blink rate in patients with blepharospasm 146
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 145
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 142
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 142
Disproportionate Impairment in Naming and Comprehension of Nouns with Relative Sparing of Verbs in a Patient who Survived Herpes Simplex Encephalitis 141
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 140
Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease. 136
Cognitive and behavioural changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 134
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease 134
The potential of solanezumab and gantenerumab to prevent Alzheimerâ s disease in people with inherited mutations that cause its early onset 133
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 133
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 132
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 132
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 130
An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities 128
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 127
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 127
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 126
Social Frailty in the COVID-19 Pandemic Era 126
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 124
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 123
Neuroanatomical Correlates of Category-specific Semantic Disorders: A Critical Survey 123
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 121
The RELN locus in Alzheimer's Disease 121
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 119
Accelerated Long-Term Forgetting Limited to the Recollection Component of Recognition Memory in a Temporal Lobe Epileptic Patient 119
Targeting oral frailty indicators of late-life cognitive disorders and depression: a systematic review 118
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 116
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 116
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease 113
Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect 111
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 111
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease? 111
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 110
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 110
Successes and failures: the latest advances in the clinical development of amyloid–β–targeting monoclonal antibodies for treating Alzheimer's disease 108
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 108
Cognitive frailty: definitions, components, and impact on disability and mortality 108
Malattia di Parkinson e altri disordini del movimento 108
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 107
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 106
Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients 106
Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study 105
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 105
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 104
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 104
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 104
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes 104
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 103
Oral frailty indicators and cardio- and cerebrovascular diseases in older age: A systematic review 102
Cognitive frailty: a potential target for secondary prevention of dementia 101
The missing ApoE allele 101
Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism 101
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders 101
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's disease 100
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease 100
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 99
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 97
The role of biomarkers in psychiatry 97
Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study 96
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 95
The need of an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson's disease 95
Oral frailty and neurodegeneration in Alzheimer's disease 94
Normal pressure hydrocephalus 93
Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation 93
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 93
The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease 91
Zolpidem in Parkinson's disease 91
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders 91
The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy 91
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? 91
Totale 13.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.015 0 73 31 71 112 51 28 151 65 53 172 208
2022/20232.086 229 235 170 227 181 258 187 145 249 72 62 71
2023/20241.315 72 362 61 61 75 124 117 51 32 46 147 167
2024/20252.690 56 54 197 105 146 106 75 133 433 277 607 501
2025/20268.803 1.260 267 748 1.198 1.150 400 1.263 500 598 743 395 281
2026/2027954 507 447 0 0 0 0 0 0 0 0 0 0
Totale 20.416